[1]
Heisterberg, J. 2021. How Should Synthetic Follow-Ons of Biological Products Be Regulated? What Are the Implications for Automatic Substitution?. Acta Pharmaceutica Hungarica. 91, 3-4 (Nov. 2021), 108-109. DOI:https://doi.org/10.33892/aph.2021.91.108-109.